IDWeek 2014

Physicians, scientists, and allied health staff from Mayo Clinic and Mayo Medical Laboratories are currently attending IDWeek 2014 in Philadelphia. View the interactive program for a list of our presentation times and locations, and be sure to visit us at booth #442 in the exhibit hall to discuss:


ENTEROVIRUS INFECTIONS

Enterovirus D68 was identified as the causative agent in an outbreak of severe respiratory illness in children in Missouri. Enterovirus infection causes mild to severe respiratory illness with severe disease found primarily in children with a history of asthma or wheezing. Molecular detection by PCR is recommended for rapid diagnosis, but will not speciate the enteroviruses. If specific serotyping is required, samples should be submitted to a state health laboratory or the CDC.

Resources:


HISTOPLASMA CAPSULATUM

The new Histoplasma Antigen, Urine test is now available at Mayo Medical Laboratories. This test should be ordered in individuals suspected to be infected with Histoplasma capsulatum.

Resources:


CHIKUNGUNYA VIRUS

As treatment of Chikungunya virus infections is largely supportive, it is important to rule out other infectious agents for which targeted therapy exists. While testing options to detect Chikungunya virus exist, availability of such assays is limited.

Resources:


HUMAN PAPILLOMAVIRUS (HPV)

To better accommodate important updates in the screening guidelines for HPV, an infection present in 20 million people in the United States and resulting in 6.2 million new infections per year, Mayo Medical Laboratories now offers testing for the detection of high-risk HPV (hrHPV), with genotyping for HPV-16 and HPV-18.

Resources:


TICK-BORNE DISEASES

Historically, only certain pockets of the United States posed a risk for tick-borne disease. However, the geographic range of ticks has expanded and large areas of the population are now at risk. Because of this increased risk, it is important that physicians recognize who to test, when to test, and what test to use.

Resources:


MYCOBACTERIA

Mayo Medical Laboratories offers unparalleled depth and breadth in identification and susceptibility testing for mycobacteria and aerobic actinomycetes. In order to complement your organization’s existing capabilities, Mayo Medical Laboratories services are available at any stage of the testing process.

Resources:


Q FEVER (Coxiella burnetii):

Our targeted test options and comprehensive next generation sequencing panel provide clinicians with a flexible and cost-effective approach to evaluating patients for hereditary colon cancer syndromes.

Resources


KPC & NDM SURVEILLANCE

Our targeted test options and comprehensive next generation sequencing panel provide clinicians with a flexible and cost-effective approach to evaluating patients for hereditary colon cancer syndromes.

Resources


TRICHOMONIASIS

Trichomonas vaginalis is a protozoan pathogen. Infection with this organism is called trichomoniasis and it is the most common curable sexually transmitted infection (STI) in the United States, with more than 3.7 million individuals infected. Since the clinical presentation is nonspecific and infection may be confused with other STIs, yeast infections, and bacterial urinary tract infections, laboratory testing is required for accurate diagnosis.

Resources

brentwestra

Brent Westra

Brent Westra is a Marketing Segment Manager at Mayo Medical Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.